Outcomes of pregnant patients with Pap smears classified as atypical glandular cells

Cytopathology

Volumn 23, Issue 6, 2012, Pages 383-388

  Slama, J ^a   Freitag, P ^a   Dundr, P ^a   Duskova, J ^a   Fischerova, D ^a   Zikan, M ^a   Pinkavova, I ^a   Cibula, D ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atypical glandular cells; Cervical adenocarcinoma; Cervical dysplasia; Colposcopy; Human papillomavirus; Pregnancy; Squamous intraepithelial lesions

Indexed keywords

ADULT; ARTICLE; ATYPICAL GLANDULAR CELL; CELL TYPE; CLINICAL ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DELIVERY; FEMALE; FIRST TRIMESTER PREGNANCY; HISTOPATHOLOGY; HUMAN; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PUNCH BIOPSY; TRANSRECTAL ULTRASONOGRAPHY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; WART VIRUS;

ADULT; CARCINOMA IN SITU; CASE-CONTROL STUDIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84870241399     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2011.00898.x     Document Type: Article

References (27)

1. Bray F, Carstensen B, Moller H et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005;14:2191-9.
2. Vizcaino AP, Moreno V, Bosch FX et al. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998;75:536-45.
3. Ving-Hung V, Bourgain C, Vlastos G et al. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. BMC Cancer 2007;23:164.
4. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24-year population-based study. Gynecol Oncol 2000;78:97-105.
5. Wright TC Jr, Massad LS, Dunton CJ et al. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. Am J Obstet Gynecol 2007;197:346-55.
6. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Dysplasia associated with atypical glandular cell Pap smears on cervical cytology. Obstet Gynecol 2005;105:494-500.
7. Flannelly G. The management of women with abnormal cervical cytology in pregnancy. Best Pract Res Clin Obstet Gynaecol 2010;24:51-60.
8. Hunter MI, Monk BJ, Tewari KS. Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease. Am J Obstet Gynecol 2008;199:3-9.
9. Tam KF. Atypical glandular cells in cervical smear during pregnancy and postpartum period. Clin Med Res 2005;3:1-2.
10. Fischerova D, Cibula D, Stenhova H et al. Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer. Int J Gynecol Cancer 2007;18:766-72.
11. Wright TC Jr, Massad LS, Dunton CJ et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007;197:340-5.
12. Hybrid Capture 2 FDA approval letter. Available at: http://www.fda.gov/cdrh/pdf/p890064s009.pdf (accessed 27 January 2007).
13. Solomon D, Davey D, Kurman R et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2120-9.
14. Connolly TP, Evans AC. Atypical Papanicolau smear in pregnancy. Clin Med Res 2005;3:13-28.
15. Adhya AK, Mahesha V, Srinivasan R et al. Atypical glandular cells in cervical smears: histological correlation and suggested plan of management based on age of the patient in low-resource setting. Cytopathology 2009;20:375-9.
16. DeSimone CP, Day ME, Tovar MM et al. Rate of pathology from atypical glandular cell Pap test classified by the Bethesda 2001 nomenclature. Obstet Gynecol 2006;107:1285-91.
17. Kobayashi TK, Okamoto H. Cytopathology of pregnancy-induced cell patterns in cervicovaginal smears. Am J Clin Pathol 2000;114(Suppl):S6-20.
18. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ; ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
19. Valdini A, Vaccaro C, Pechinsky G, Abernathy V. Incidence and evaluation of an AGUS Papanicolaou smear in primary care. J Am Board Fam Pract 2001;14:172-7.
20. Kumar N, Bongiovanni M, Molliet MJ et al. Diverse glandular pathologies coexist with high-grade squamous intraepithelial lesion in cyto-histological review of atypical glandular cells on ThinPrep specimens. Cytopathology 2009;20:351-8.
21. Ullal A, Roberts M, Bulmer JN, Mathers ME, Wadehra V. The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia. Cytopathology 2009;20:359-66.
22. Frega A, Scirpa P, Corosu R et al. Clinical management and follow-up of squamous intraepithelial cervical lesions during pregnancy and postpartum. Anticancer Res 2007;27:2743-6.
23. Kim TJ, Kim HS, Park CT et al. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Gynecol Oncol 1999;73:292-8.
24. Michael CW, Esfahani FM. Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol 1997;17:99-107.
25. Chhieng DC, Elgert P, Cangiarella JF, Cangiarella JF, Cohen JM. Significance of AGUS Pap smears in pregnant and postpartum women. Acta Cytol 2001;45:294-9.
26. Derchain SF, Rabelo-Santos SH, Sarian LO et al. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol 2004;95:618-23.
27. Krane JF, Lee KR, Sun D, Yuan L, Crum CP. Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing. Am J Clin Pathol 2004;121:87-92.